Honasa Consumer Ltd

BSE: 544014

32

total announcements

544014.BO · 15 min delayed

BSEResultResults13 Aug 2026

Honasa Consumer Ltd

Unaudited Financial Results for the quarter ended June 30, 2026

Honasa Consumer Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the company's board of directors approving the results based on the recommendation of the Audit Committee. The results include the unaudited standalone and consolidated financial results of the company for the quarter, along with a limited review report issued by the Statutory Auditors.

Read more →📎 1 attachment
BSEBoard MeetingResults13 Aug 2026

Honasa Consumer Ltd

Outcome of Board Meeting held today i.e. August 13, 2026

Honasa Consumer Ltd's board of directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, based on the recommendation of the Audit Committee. The financial results along with limited review reports are enclosed.

Read more →📎 1 attachment
BSECompany Update▲ PositiveMgmt Change6 Aug 2026

Honasa Consumer Ltd

Update on Senior Management

Honasa Consumer Ltd has elevated Nilesh Kotalwar as Chief Marketing Officer, effective August 06, 2026, to lead the company's integrated marketing function across its portfolio of brands.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A23 Jun 2026

Honasa Consumer Ltd

Press release

Honasa Consumer Ltd. announced the strategic acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy and dermatologist network. This acquisition marks Honasa's entry into the high-growth nutraceuticals category, specifically targeting "inside-out" beauty, under a newly formed subsidiary, Honasa Health. Fluence Pharma reported ~INR 40 Crore revenue and over 20% EBITDA margin in FY26, and Honasa aims to leverage Fluence's science with its own brand-building and digital distribution capabilities.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A23 Jun 2026

Honasa Consumer Ltd

Approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary

Honasa Consumer Ltd announced the acquisition of a 58% equity stake in Fluence Pharma Private Limited, a company offering condition-specific OTC supplements under brands like "Hair Fact, Skin Fact, and Pro Fact." The acquisition, valued at approximately ₹135 Crores enterprise value for the initial stake, strategically marks Honasa's entry into the high-growth nutraceuticals market, with plans to acquire the remaining 42% over the next 5-7 years. Additionally, Honasa will incorporate a wholly-owned subsidiary, 'Honasa Health Private Limited,' to manage its new B2C nutraceuticals operations.

Read more →📎 1 attachment
← PreviousPage 2 of 2